跳至主要内容
临床试验/NCT02267005
NCT02267005已完成不适用

The Effect of Creatine Supplementation on Muscle Function in Childhood Myositis

The Hospital for Sick Children1 个研究点 分布在 1 个国家目标入组 13 人开始时间: 2015年3月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
13
试验地点
1
主要终点
Muscle function

研究概览

简要总结

This project will bring together a multidisciplinary team of pediatric rheumatologists, neurologists, metabolic geneticists and exercise physiologists to determine the effect of creatine (CR) supplementation on muscle function and muscle metabolism in children with Dermatomyositis (DM). The investigators propose using well-established exercise testing techniques as well as new, powerful exercise imaging protocols in order to better delineate the effects of CR on muscle pathophysiology in a non-invasive way. Evidence from this study will provide information regarding the effect of creatine supplementation on muscle function in DM. Improvements in muscle function and fatigue through CR use may also contribute to an improvement in quality of life and have significant clinical implications for the treatment of children with DM.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Supportive Care
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
7 Years 至 18 Years(Child, Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Ages 7 to 18 years
  • •Diagnosis of probable JDM (onset <16 years) according to Bohan and Peter criteria
  • •Subjects on a stable course of medication (unlikely to change over study treatment period as determined by the treating physician)
  • •Minimum height of 132.5cm

排除标准

  • •Subjects newly diagnosed with JDM within the previous 6 months
  • •Subjects unable to cooperate with study procedures, or too weak to participate in the exercise testing
  • •Subjects with impaired kidney function as determined from baseline visit screening lab values
  • •Subjects who are currently pregnant or planning to become pregnant within the study period
  • •Subjects who are shorter than 132.5cm

研究组 & 干预措施

Placebo

Placebo Comparator

patients on this arm will be given a placebo glucose tablet supplement

干预措施: Glucose Tablet (Dietary Supplement)

Treatment

Experimental

patients on this arm will be treated with creapure supplements

干预措施: Creapure (Dietary Supplement)

结局指标

主要结局

Muscle function

时间窗: 6 months

Will be determined by mean power output using a Wingate cycle ergometer protocol

次要结局

  • Fatigue(6 months)
  • Adherence(6 months)
  • Muscle metabolism(6 months)
  • Quality of life(6 months)
  • Disease Activity(6 months)
  • Muscle Strength(6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Brian Feldman

Division Head, Rheumatology / Sr Scientist

The Hospital for Sick Children

研究点 (1)

Loading locations...

相似试验